Mechanism of Action of G-Quadruplex–Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma

Abstract

T-oligo, a guanine-rich oligonucleotide homologous to the 3'-telomeric overhang of telomeres, elicits potent DNA-damage responses in melanoma cells; however, its mechanism of action is largely unknown. Guanine-rich oligonucleotides can form G-quadruplexes (G4), which are stabilized by the hydrogen bonding of guanine residues. In this study, we confirmed the G4-forming capabilities of T-oligo using nondenaturing PAGE, nuclear magnetic resonance, and immunofluorescence. Using an anti-G-quadruplex antibody, we showed that T-oligo can form G4 in the nuclei of melanoma cells. Furthermore, using DNase I in a nuclease degradation assay, G4-T-oligo was found to be more stable than single-stranded T-oligo. G4-T-oligo had decreased antiproliferative effects compared with single-stranded T-oligo. However, G4-T-oligo has similar cellular uptake as single-stranded T-oligo, as shown by FACS analysis. Inhibition of JNK, which causes DNA damage-induced apoptosis, partially reversed the antiproliferative activity of T-oligo. T-oligo also inhibited mRNA expression of human telomerase reverse transcriptase, a catalytic subunit of telomerase that was reversed by JNK inhibition. Furthermore, two shelterin complex proteins TRF2/POT1 were found to be up-regulated and bound by T-oligo, suggesting that T-oligo may mediate dissociation of these proteins from the telomere overhang. These studies show that T-oligo can form a G-quadruplex and that the antitumor effects of T-oligo may be mediated through POT1/TRF2 and via human telomerase reverse transcriptase inhibition through JNK activation.

PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer

“…CRC cells (2 × 10 3 ) were grown overnight on a Lab-Tek®II CC2 Chamber slideTM System (Cat#154917, Nunc, Rochester, NY, USA) as described previously [16,62]. Cells were fixed with chilled methanol for 10 minutes and washed with PBS.…”

Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

“…4 The most frequently found pathogen is Staphylococcus aureus (S. aureus), infecting 44-76% of CTCL patients. 5,6 In a murine CTCL disease model, it has been shown that bacterial infections aggravate the disease 7 and a reduction of colonizing bacteria in CTCL patients with antibiotics has been associated with clinical improvement and a decrease in tumour burden. 8,9 This suggests that S. aureus and its toxins fuel disease progression (as reviewed in 10 ).…”

Therapeutic strategies for targeting telomerase in cancer

“…T‐oligo has shown anticancer activity in multiple cancer cell lines in vitro . In a pancreatic cancer cells experiment, cell viability decreased to 26% within a 48‐hour period after treatment with T‐oligo .…”